DK0723552T3 - Oligopeptider afledt af fragmenter af C-reaktivt protein - Google Patents

Oligopeptider afledt af fragmenter af C-reaktivt protein

Info

Publication number
DK0723552T3
DK0723552T3 DK94916966T DK94916966T DK0723552T3 DK 0723552 T3 DK0723552 T3 DK 0723552T3 DK 94916966 T DK94916966 T DK 94916966T DK 94916966 T DK94916966 T DK 94916966T DK 0723552 T3 DK0723552 T3 DK 0723552T3
Authority
DK
Denmark
Prior art keywords
fragments
pct
reactive protein
oligopeptides derived
derived
Prior art date
Application number
DK94916966T
Other languages
English (en)
Inventor
Massimo Pinori
Patrizia Caretto
Flavio Leoni
Fabrizio Marcucci
Gianni Gromo
Paolo Mascagni
Silvana Cappelletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Application granted granted Critical
Publication of DK0723552T3 publication Critical patent/DK0723552T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94916966T 1993-10-12 1994-05-16 Oligopeptider afledt af fragmenter af C-reaktivt protein DK0723552T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
PCT/EP1994/001574 WO1995010531A1 (en) 1993-10-12 1994-05-16 Oligopeptides derived from c-reactive protein fragments

Publications (1)

Publication Number Publication Date
DK0723552T3 true DK0723552T3 (da) 2003-02-24

Family

ID=11367010

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916966T DK0723552T3 (da) 1993-10-12 1994-05-16 Oligopeptider afledt af fragmenter af C-reaktivt protein

Country Status (19)

Country Link
US (1) US6057295A (da)
EP (1) EP0723552B1 (da)
JP (1) JP3221881B2 (da)
KR (1) KR100363408B1 (da)
CN (1) CN1041524C (da)
AT (1) ATE226591T1 (da)
AU (1) AU684511B2 (da)
CA (1) CA2173939C (da)
DE (1) DE69431603T2 (da)
DK (1) DK0723552T3 (da)
ES (1) ES2185652T3 (da)
FI (1) FI961584L (da)
HU (1) HUT75538A (da)
IL (1) IL109761A0 (da)
IT (1) IT1271486B (da)
NO (1) NO961423L (da)
PT (1) PT723552E (da)
WO (1) WO1995010531A1 (da)
ZA (1) ZA943610B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342481B1 (en) * 1993-10-12 2002-01-29 Italfarmaco S.P.A. Oligopeptides derived from C-reactive protein fragments
EP1408031A1 (en) * 2002-10-09 2004-04-14 3 D Gene Pharma Pyrolidine derivatives useful in treatment of hepatitis C virus infection
EP2898900B1 (en) 2008-09-19 2017-11-15 Nektar Therapeutics Polymer conjugates of ziconotide
ES2678143T3 (es) 2010-01-19 2018-08-09 President And Fellows Of Harvard College Opsonina obtenida por ingeniería genética para la detección y el tratamiento de microorganismos patógenos
EP2734843A2 (en) 2011-07-18 2014-05-28 President and Fellows of Harvard College Engineered microbe-targeting molecules and uses thereof
EP2976642A4 (en) 2013-03-15 2016-09-21 Harvard College METHOD AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR RECORDING OF A TARGET UNIT
US9988617B2 (en) 2013-05-21 2018-06-05 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3546474B1 (en) 2013-12-18 2021-07-07 President and Fellows of Harvard College Crp capture/detection of gram positive bacteria
CN108289928B (zh) 2015-08-06 2024-09-17 哈佛大学校长及研究员协会 改进的微生物-结合分子和其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
EP0253190B1 (en) * 1986-07-16 1992-12-30 ENIRICERCHE S.p.A. Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Also Published As

Publication number Publication date
WO1995010531A1 (en) 1995-04-20
CA2173939A1 (en) 1995-04-20
ITMI932154A0 (it) 1993-10-12
NO961423D0 (no) 1996-04-11
FI961584A7 (fi) 1996-04-11
AU6844194A (en) 1995-05-04
IT1271486B (it) 1997-05-28
NO961423L (no) 1996-06-10
FI961584A0 (fi) 1996-04-11
HUT75538A (en) 1997-05-28
CA2173939C (en) 2002-08-27
CN1041524C (zh) 1999-01-06
DE69431603T2 (de) 2003-03-13
ATE226591T1 (de) 2002-11-15
FI961584L (fi) 1996-04-11
JP3221881B2 (ja) 2001-10-22
AU684511B2 (en) 1997-12-18
EP0723552B1 (en) 2002-10-23
ITMI932154A1 (it) 1995-04-12
KR100363408B1 (ko) 2003-02-11
DE69431603D1 (de) 2002-11-28
CN1133048A (zh) 1996-10-09
EP0723552A1 (en) 1996-07-31
HU9600934D0 (en) 1996-08-28
ZA943610B (en) 1995-01-25
ES2185652T3 (es) 2003-05-01
US6057295A (en) 2000-05-02
PT723552E (pt) 2003-02-28
IL109761A0 (en) 1994-08-26
JPH09503200A (ja) 1997-03-31

Similar Documents

Publication Publication Date Title
CY1119263T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
BR0112111A (pt) Realce de respostas imunes mediadas por proteìna de fusão de anticorpo-citocina por tratamento combinado com agentes de realce de captação de imunocitocina
DK0733109T3 (da) BMP-12, BMP-13 og seneinducerende præparater dermed
EP1474121A4 (en) SMALL MOLECULAR ANTAGONISTS OF PROTEINS OF THE BCL2 FAMILY
DK1068241T3 (da) Antistofvarianter og fragmenter deraf
EP1322307A4 (en) METHOD FOR THE TREATMENT OF CELL PROLIFERATION TROUBLES AND VIRUS INFECTIONS
DK0793674T3 (da) Inhibitorer af human neutrofil elastase
NO307408B1 (no) Aminosukker og glykosaminglykansammensetning for behandling og reparasjon av bindevev
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
FI961584A0 (fi) C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
IL145689A0 (en) Methods
WO2003027251A3 (en) Novel molecules of the pyrin domain protein family and uses thereof
DE69534753D1 (de) Nierenpolycystose-gen
EA200001127A1 (ru) Бактериальные феромоны и их использование
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
NO20060781L (no) Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser
BR0108187A (pt) Moléculas trade e usos relacionados com as mesmas
DK0952982T3 (da) Hidtil ukendte hepatitis B inhibitorer
LT2001045A (en) Compositions and use thereof for downmodulating the immune response to therapeutic proteins
ATE239499T1 (de) Protein-disulfid-isomerasen enthaltende pharmazeutische zusammensetzungen